Tag: R&D

Research and development (R&D or R+D), also known in Europe as research and technical (or technological) development (RTD), is a general term for activities in connection with corporate or governmental innovation. Research and development is situated at the front end of the innovation life cycle, which may end with commercialization.

Canadian scientists created a device to make drug testing more efficient

Engineers from McMaster University (Ontario, Canada) have devised a way to make testing for new drugs more efficient and affordable, and reduce the time for helpful medications to reach the public.

French biotech obtained two US patents for CAR-T research

Cellectis, a French clinical-stage biopharmaceutical company, announced the issuance of two US patents for the invention of certain uses of RNA-guided endonucleases.

Roche acquires cancer software startup Flatiron Health

The world’s largest biotech company Roche and Flatiron Health, Inc. announced that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health.

ImmunoQure enters into exclusive partnership with Servier

ImmunoQure, a German biotech company, and the international pharmaceutical company Servier announced the establishment of an exclusive partnership for the development of a therapeutic autoantibody neutralizing interferon-alpha.

Evotec and MaRS Innovation identified their first drug discovery project

Evotec AG (Germany) and MaRS Innovation (Canada) announced that they have identified the first project to be developed under their LAB150 partnership.

Roivant Sciences strikes a licensing deal with Poxel

lab research
Roivant Sciences, a global healthcare company, and POXEL SA, a biopharmaceutical company, announced the signing of a strategic development and license agreement for imeglimin

Charles River Laboratories acquires MPI Research

Charles River Laboratories International, Inc. announced that it has entered into a definitive agreement to acquire MPI Research, a US contract research organization, for approximately $800 million.

Sirenas started a research collaboration with Bristol-Myers Squibb

Sirenas, a biotechnology company harnessing computational approaches to discover therapeutics derived from the global microbiome, entered into a multi-target research collaboration agreement with Bristol-Myers Squibb Company

UCB and Novo Seeds launched Syndesi Therapeutics

lab research
The creation of Syndesi Therapeutics became possible as the result of a partnership between UCB, a global biopharmaceutical company headquartered in Belgium, and a syndicate of Belgian and international investors

A new training center will be established in NovaMedica Innotech

nova medica
NovaMedica has announced the collaboration in the area of knowledge and technology transfer between NovaMedica Innotech, an R&D center, and Evonik, a German company

Takeda will jointly work with Fujifilm on regenerative medicine therapies

FUJIFILM Corporation and Takeda Pharmaceutical Company Ltd., announced a collaboration to develop regenerative medicine therapies using cardiomyocytes derived from Induced Pluripotent Stem Cells

Johnson & Johnson Innovation creates a research incubator in Belgium

test tubes
The Belgium-based JLINX incubator – a collaboration launched in March 2016 between Janssen Pharmaceutica NV and Bioqube Ventures – will become part of the global Johnson & Johnson Innovation network

ShanghaiTech University and Jing Medicine starts a research collaboration

good laboratory practice
ShanghaiTech University and Jing Medicine Technology Ltd. announced an over $100 million strategic collaboration to discover and develop novel small molecule anti-cancer drugs

Volgograd State Medical University launches a scientific center

volgograd scientific center
The project is a priority for the Southern Federal District and it is being implemented under the program "The Development of Pharmaceutical and Medical industry of the Russian Federation for the Period up to 2020 and Beyond."

WHO exposed striking gaps and inequalities in Health R&D

One year ago, the World Health Organization launched a new initiative to gather information and provide an accurate picture of where and how R&D monies are being spent

Agilent Technologies partners with Science Exchange

Agilent Technologies, an American public research, development and manufacturing company, announced a partnership with Science Exchange, the world's leading enterprise platform for outsourced research and development services.